Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Hospira Inc (HSP) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Hospira Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1274057.
Total stock buying since 2014: $0.
Total stock sales since 2014: $29,772,821.
Total stock option exercises since 2014: $108,883,894.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2015 | 0 | $0 | 64,737 | $5,354,864 | 2,428,343 | $94,635,822 |
2014 | 0 | $0 | 434,203 | $24,417,957 | 422,656 | $14,248,072 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2015-09 | 0 | $0 | 0 | $0 | 2,386,449 | $93,073,647 |
2015-05 | 0 | $0 | 4,000 | $352,448 | 0 | $0 |
2015-03 | 0 | $0 | 21,833 | $1,910,147 | 4,990 | $176,446 |
2015-02 | 0 | $0 | 26,904 | $2,353,079 | 26,904 | $953,929 |
2015-01 | 0 | $0 | 12,000 | $739,190 | 10,000 | $431,800 |
2014-12 | 0 | $0 | 31,850 | $1,929,400 | 31,850 | $1,145,530 |
2014-11 | 0 | $0 | 263,353 | $15,611,445 | 255,806 | $8,585,142 |
2014-10 | 0 | $0 | 10,000 | $500,400 | 10,000 | $431,800 |
2014-09 | 0 | $0 | 10,000 | $527,400 | 10,000 | $431,800 |
2014-08 | 0 | $0 | 10,000 | $554,880 | 10,000 | $326,650 |
2014-07 | 0 | $0 | 10,000 | $515,000 | 10,000 | $221,500 |
2014-06 | 0 | $0 | 10,000 | $508,210 | 10,000 | $221,500 |
2014-05 | 0 | $0 | 89,000 | $4,271,222 | 85,000 | $2,884,150 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2015-09-03 | Gendron Mary (SVP, Chief Information Officer) | Option Ex | 17,028 | 26.16 | 445,367 |
2015-09-03 | Yoskowitz Marc J (SVP, Strategy & Corporate Dev) | Option Ex | 63,459 | 40.03 | 2,540,263 |
2015-09-03 | Bedward Royce (SVP, General Counsel and Sec'y) | Option Ex | 80,915 | 41.85 | 3,386,454 |
2015-09-03 | Stober Matthew R (SVP, Operations) | Option Ex | 69,103 | 26.75 | 1,848,712 |
2015-09-03 | Kaufman Zena G. (SVP, Quality) | Option Ex | 101,036 | 35.67 | 3,603,954 |
2015-09-03 | Davies Richard John (SVP, Chief Commercial Officer) | Option Ex | 191,175 | 35.67 | 6,819,212 |
2015-09-03 | Endicott David J. (Pres., Hospira Medical Devices) | Option Ex | 72,971 | 43.01 | 3,138,482 |
2015-09-03 | Meyers Kenneth F (SVP, Chief Human Resources Ofr) | Option Ex | 149,321 | 41.85 | 6,249,382 |
2015-09-03 | Ramachandra Sumant (SVP & Chief Scientifc Ofcr) | Option Ex | 117,790 | 40.03 | 4,715,133 |
2015-09-03 | Hoffman Richard J (CVP, Controller & CAO) | Option Ex | 94,239 | 41.85 | 3,944,090 |
2015-09-03 | Werner Thomas E (SVP, Finance & CFO) | Option Ex | 296,776 | 37.59 | 11,154,622 |
2015-09-03 | Smith Brian J (SVP and Special Counsel) | Option Ex | 195,091 | 41.85 | 8,164,948 |
2015-09-03 | Ball F Michael (Chief Executive Officer) | Option Ex | 937,545 | 39.53 | 37,063,028 |
2015-05-21 | Bowles Barbara L | Sale | 4,000 | 88.11 | 352,448 |
2015-03-02 | Stober Matthew R (SVP, Operations) | Sale | 21,833 | 87.49 | 1,910,147 |
2015-03-02 | Stober Matthew R (SVP, Operations) | Option Ex | 4,990 | 35.36 | 176,446 |
2015-02-27 | Stober Matthew R (SVP, Operations) | Sale | 14,227 | 87.48 | 1,244,521 |
2015-02-27 | Stober Matthew R (SVP, Operations) | Option Ex | 14,227 | 28.95 | 411,871 |
2015-02-26 | Stober Matthew R (SVP, Operations) | Sale | 11,111 | 87.46 | 971,768 |
2015-02-26 | Stober Matthew R (SVP, Operations) | Option Ex | 11,111 | 42.70 | 474,439 |
2015-02-17 | Werner Thomas E (SVP, Finance & CFO) | Sale | 1,566 | 87.35 | 136,790 |
2015-02-17 | Werner Thomas E (SVP, Finance & CFO) | Option Ex | 1,566 | 43.18 | 67,619 |
2015-01-15 | Werner Thomas E (SVP, Finance & CFO) | Sale | 10,000 | 61.56 | 615,590 |
2015-01-15 | Werner Thomas E (SVP, Finance & CFO) | Option Ex | 10,000 | 43.18 | 431,800 |
2015-01-12 | Stober Matthew R (SVP, Operations) | Sale | 2,000 | 61.80 | 123,600 |
2014-12-15 | Werner Thomas E (SVP, Finance & CFO) | Sale | 10,000 | 61.09 | 610,950 |
2014-12-15 | Werner Thomas E (SVP, Finance & CFO) | Option Ex | 10,000 | 43.18 | 431,800 |
2014-12-02 | Hoffman Richard J (CVP, Controller & CAO) | Sale | 21,850 | 60.34 | 1,318,450 |
2014-12-02 | Hoffman Richard J (CVP, Controller & CAO) | Option Ex | 21,850 | 32.66 | 713,730 |
2014-11-28 | Sokolov Jacque J | Sale | 7,547 | 60.32 | 455,204 |
2014-11-25 | Yoskowitz Marc J (SVP, Strategy & Corporate Dev) | Sale | 11,523 | 59.93 | 690,607 |
2014-11-25 | Yoskowitz Marc J (SVP, Strategy & Corporate Dev) | Option Ex | 11,523 | 37.36 | 430,499 |
2014-11-24 | Meyers Kenneth F (SVP, Chief Human Resources Ofr) | Sale | 46,250 | 59.59 | 2,755,852 |
2014-11-24 | Meyers Kenneth F (SVP, Chief Human Resources Ofr) | Option Ex | 46,250 | 22.15 | 1,024,437 |
2014-11-24 | Smith Brian J (SVP and Special Counsel) | Sale | 136,100 | 59.20 | 8,057,392 |
2014-11-24 | Smith Brian J (SVP and Special Counsel) | Option Ex | 136,100 | 34.92 | 4,753,292 |
2014-11-21 | Smith Brian J (SVP and Special Counsel) | Sale | 49,600 | 59.24 | 2,938,155 |
2014-11-21 | Smith Brian J (SVP and Special Counsel) | Option Ex | 49,600 | 37.19 | 1,844,376 |
2014-11-20 | Bedward Royce (SVP, General Counsel and Sec'y) | Sale | 2,333 | 58.68 | 136,895 |
2014-11-20 | Bedward Royce (SVP, General Counsel and Sec'y) | Option Ex | 2,333 | 43.18 | 100,738 |
2014-11-17 | Werner Thomas E (SVP, Finance & CFO) | Sale | 10,000 | 57.73 | 577,340 |
2014-11-17 | Werner Thomas E (SVP, Finance & CFO) | Option Ex | 10,000 | 43.18 | 431,800 |
2014-10-17 | Werner Thomas E (SVP, Finance & CFO) | Sale | 10,000 | 50.04 | 500,400 |
2014-10-17 | Werner Thomas E (SVP, Finance & CFO) | Option Ex | 10,000 | 43.18 | 431,800 |
2014-09-15 | Werner Thomas E (SVP, Finance & CFO) | Sale | 10,000 | 52.74 | 527,400 |
2014-09-15 | Werner Thomas E (SVP, Finance & CFO) | Option Ex | 10,000 | 43.18 | 431,800 |
2014-08-15 | Werner Thomas E (SVP, Finance & CFO) | Sale | 10,000 | 55.49 | 554,880 |
2014-08-15 | Werner Thomas E (SVP, Finance & CFO) | Option Ex | 10,000 | 32.66 | 326,650 |
2014-07-15 | Werner Thomas E (SVP, Finance & CFO) | Sale | 10,000 | 51.50 | 515,000 |
2014-07-15 | Werner Thomas E (SVP, Finance & CFO) | Option Ex | 10,000 | 22.15 | 221,500 |
2014-06-16 | Werner Thomas E (SVP, Finance & CFO) | Sale | 10,000 | 50.82 | 508,210 |
2014-06-16 | Werner Thomas E (SVP, Finance & CFO) | Option Ex | 10,000 | 22.15 | 221,500 |
2014-05-21 | Werner Thomas E (SVP, Finance & CFO) | Sale | 30,000 | 47.98 | 1,439,250 |
2014-05-21 | Werner Thomas E (SVP, Finance & CFO) | Option Ex | 30,000 | 22.15 | 664,500 |
2014-05-16 | Curran Connie R | Sale | 2,000 | 47.46 | 94,912 |
2014-05-14 | Bowles Barbara L | Sale | 2,000 | 47.77 | 95,540 |
2014-05-13 | Hoffman Richard J (CVP, Controller & CAO) | Sale | 15,000 | 48.07 | 721,080 |
2014-05-13 | Hoffman Richard J (CVP, Controller & CAO) | Option Ex | 15,000 | 41.39 | 620,850 |
2014-05-12 | Smith Brian J (SVP and Special Counsel) | Sale | 40,000 | 48.01 | 1,920,440 |
2014-05-12 | Smith Brian J (SVP and Special Counsel) | Option Ex | 40,000 | 39.97 | 1,598,800 |
Insider trading activities including stock purchases, stock sales, and option exercises of HSP listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Hospira Inc (symbol HSP, CIK number 1274057) see the Securities and Exchange Commission (SEC) website.